IRF1 and cancer: Nevertheless, our findings suggest that IRF1 expression can be used to identify subclasses of leukemia with diverse underlying mechanisms and clinical characteristics, including cancer-associated gene signatures, differences in cell proliferation, survival, DNA damage responses, and differentiation, as well as in karyotype and cytogenetic risk distribution.